je.st
news
Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520
2014-06-14 04:22:56| Biotech - Topix.net
Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today reaffirmed its belief that it has broad access to intellectual property required to develop ARC-520, its clinical candidate against chronic hepatitis B infection.
Tags: issues
statement
property
protection
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||